Thomas R. Parr Jr.

Chief Scientific Officer, Targanta Therapeutics Corporation.

Companies

Spero Therapeutics, Inc.Chief Scientific Officer Nov 1, 2017 to Jan 2, 2019¹
Targanta Therapeutics CorporationChief Scientific Officer Oct 10, 2007 to Feb 8, 2008²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSpero Therapeutics, Inc., Chief Scientific Officer
2
SEC EDGARTarganta Therapeutics Corporation, Chief Scientific Officer